FI855158A - Nya allylaminer. - Google Patents

Nya allylaminer. Download PDF

Info

Publication number
FI855158A
FI855158A FI855158A FI855158A FI855158A FI 855158 A FI855158 A FI 855158A FI 855158 A FI855158 A FI 855158A FI 855158 A FI855158 A FI 855158A FI 855158 A FI855158 A FI 855158A
Authority
FI
Finland
Prior art keywords
allylaminer
nya
nya allylaminer
Prior art date
Application number
FI855158A
Other languages
English (en)
Other versions
FI81794B (fi
FI855158A0 (fi
FI81794C (fi
Inventor
Thomas M Bargar
Jr Robert Broersma
James R Mccarthy
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI855158A0 publication Critical patent/FI855158A0/fi
Publication of FI855158A publication Critical patent/FI855158A/fi
Publication of FI81794B publication Critical patent/FI81794B/fi
Application granted granted Critical
Publication of FI81794C publication Critical patent/FI81794C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/08Hydrogen atoms or radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI855158A 1984-12-31 1985-12-27 Foerfarande foer framstaellning av terapeutiskt anvaendbar allylamin. FI81794C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68762884A 1984-12-31 1984-12-31
US68762884 1984-12-31

Publications (4)

Publication Number Publication Date
FI855158A0 FI855158A0 (fi) 1985-12-27
FI855158A true FI855158A (fi) 1986-07-01
FI81794B FI81794B (fi) 1990-08-31
FI81794C FI81794C (fi) 1990-12-10

Family

ID=24761167

Family Applications (1)

Application Number Title Priority Date Filing Date
FI855158A FI81794C (fi) 1984-12-31 1985-12-27 Foerfarande foer framstaellning av terapeutiskt anvaendbar allylamin.

Country Status (21)

Country Link
US (1) US4788301A (fi)
EP (1) EP0187390B1 (fi)
JP (1) JPS61197576A (fi)
KR (1) KR900003373B1 (fi)
CN (1) CN1006383B (fi)
AR (1) AR241137A1 (fi)
AT (1) ATE55386T1 (fi)
AU (1) AU587591B2 (fi)
CA (1) CA1258264A (fi)
DE (1) DE3579145D1 (fi)
DK (1) DK164504C (fi)
ES (1) ES8703866A1 (fi)
FI (1) FI81794C (fi)
GR (1) GR853149B (fi)
HU (1) HU193619B (fi)
IE (1) IE58187B1 (fi)
NO (1) NO168581C (fi)
NZ (1) NZ214698A (fi)
PH (1) PH21649A (fi)
PT (1) PT81772B (fi)
ZA (1) ZA859888B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1293511C (en) * 1986-12-23 1991-12-24 James R. Mccarthy Allenyl amines
US5112852A (en) * 1986-12-23 1992-05-12 Merrell Dow Pharmaceuticals Inc. Allenyl amines
US4847288A (en) * 1986-12-23 1989-07-11 Merrell Dow Pharmaceuticals Inc. Allenyl amines
NZ223583A (en) * 1987-02-26 1990-02-26 Merrell Dow Pharma 2- or 3-thienyl-or-furyl-2-propyn-1-amines and antihypertensive compositions
US20110065632A1 (en) * 2008-05-14 2011-03-17 Zheng Xin Dong Pharmaceutical compositions of somatostatin-dopamine conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454158A (en) * 1981-06-01 1984-06-12 Merrell Toraude Et Compagnie Allyl amine MAO inhibitors
FR2508456A1 (fr) * 1981-06-30 1982-12-31 Sanofi Sa Procede de preparation de (thienyl-2)-2 ethylamines et (thienyl-3)-2 ethylamines

Also Published As

Publication number Publication date
US4788301A (en) 1988-11-29
CN1006383B (zh) 1990-01-10
EP0187390A3 (en) 1987-03-25
ZA859888B (en) 1986-09-24
EP0187390B1 (en) 1990-08-08
HU193619B (en) 1987-11-30
ES8703866A1 (es) 1987-03-01
NZ214698A (en) 1988-08-30
GR853149B (fi) 1986-04-20
IE853326L (en) 1986-06-30
CN85109434A (zh) 1986-09-24
DK607785D0 (da) 1985-12-30
DK607785A (da) 1986-07-01
AR241137A1 (es) 1991-11-29
AR241137A2 (es) 1991-11-29
PT81772B (pt) 1987-10-20
CA1258264A (en) 1989-08-08
NO168581B (no) 1991-12-02
DE3579145D1 (en) 1990-09-13
ATE55386T1 (de) 1990-08-15
PT81772A (en) 1986-01-02
NO855353L (no) 1986-07-01
PH21649A (en) 1988-01-13
KR900003373B1 (ko) 1990-05-16
NO168581C (no) 1992-03-11
ES550570A0 (es) 1987-03-01
FI81794B (fi) 1990-08-31
DK164504B (da) 1992-07-06
KR860004874A (ko) 1986-07-14
FI855158A0 (fi) 1985-12-27
FI81794C (fi) 1990-12-10
AU587591B2 (en) 1989-08-24
DK164504C (da) 1992-11-23
IE58187B1 (en) 1993-07-28
EP0187390A2 (en) 1986-07-16
JPS61197576A (ja) 1986-09-01
HUT40099A (en) 1986-11-28
AU5173085A (en) 1986-07-10

Similar Documents

Publication Publication Date Title
FI855118A (fi) Foerfarande foer framstaellning av nya peptid-aldehyder.
FI852515A0 (fi) Foerfarande foer framstaellning av nya gangliosidderivat.
FI80883B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensotiazol- och bensotiofenderivat.
FI861750A0 (fi) Nya foereningar.
FI854434A0 (fi) Nya 5-amino-4-hydroxivaleryl-derivat.
FI862801A (fi) Nya kemiska foereningar.
FI851837A0 (fi) Foerfarande foer framstaellning av nya kompositioner.
FI853336A0 (fi) Nya medelst heterocyklisk acylgrupp substituerade aminoetrar.
FI852694L (fi) Nya isoindolinyl-alkyl-piperaziner.
FI850130L (fi) Nya 8 -asylaminoergoliner.
FI853181L (fi) Nya 6-substituerade mitomycinderivat.
FI854298A0 (fi) Framstaellningsfoerfarande av nya tienopyridinderivat.
FI855158A0 (fi) Nya allylaminer.
FI854088L (fi) Foerfarande foer framstaellning av nya pyridinderivat.
FI853535L (fi) Foerfarande foer framstaellning av nya bensazolderivat.
FI853415A0 (fi) Framstaellning foer nya diarylfoereningar.
FI853005A0 (fi) Nya aminoalkylpenem-foereningar.
FI841292A (fi) Nya timololmellanprodukter.
FI851774L (fi) Foerfarande foer framstaellning av nya kinolinderivat.
FI862679A (fi) Nya foereningar.
FI851577L (fi) Foerfarande foer framstaellning av nya pyranoderivat.
FI882241A0 (fi) Nya mellanprodukter.
FI844007L (fi) Nya kemiska foereningar.
FI921848A0 (fi) Nya pleuromutilinderivator.
FI853969A0 (fi) Foerfarande foer framstaellning av nya nukleosidderivat med antiherpetiska egenskaper.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: MERRELL DOW PHARMACEUTICALS INC.